Status:

COMPLETED

Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)

Lead Sponsor:

Hellenic Oncology Research Group

Collaborating Sponsors:

University Hospital of Crete

Conditions:

Non Small Cell Lung Cancer

Eligibility:

All Genders

18-80 years

Phase:

PHASE3

Brief Summary

The second-line treatment in advanced NSCLC has been currently proved effective in prolonging overall survival and improving quality of life. Both pemetrexed and erlotinib have been approved for secon...

Detailed Description

This trial will compare the efficacy of pemetrexed versus erlotinib in pretreated patients with advanced NSCLC.

Eligibility Criteria

Inclusion

  • Histologically- or cytologically- confirmed Non-Small-Cell Lung Cancer adenocarcinoma
  • Stage IIIB/IV
  • Failure to prior chemotherapy
  • Presence of two-dimensional measurable disease. The measurable disease should not have been irradiated
  • Absence or irradiated and stable central nervous system metastatic disease.
  • Life expectancy of more than 3 months
  • Tissue sample desired for genomic study
  • Age ≥ 18 years
  • Performance status (WHO) \< 3
  • For patients \> 65 years old: "non-frail" according to comprehensive geriatric assessment
  • Adequate bone marrow function (absolute neutrophil count \> 1000/mm\^3, platelet count \> 100000/mm\^3, hemoglobin \> 9gr/mm\^3)
  • Adequate liver (bilirubin \< 1.5 times upper limit of normal and SGOT/SGPT \< 2 times upper limit of normal) and renal function (creatinine \< 2mg/dl)
  • Presence of a reliable care giver for patients \> 65 years old
  • Informed consent.

Exclusion

  • Psychiatric illness or social situation that would preclude study compliance
  • Other concurrent uncontrolled illness
  • Other invasive malignancy within the past 5 years except nonmelanoma skin cancer

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2010

Estimated Enrollment :

320 Patients enrolled

Trial Details

Trial ID

NCT00440414

Start Date

April 1 2006

End Date

April 1 2010

Last Update

August 19 2010

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

University General Hospital of Alexandroupolis, Dep of Medical Oncology

Alexandroupoli, Greece

2

401 Military Hospital, Medical Oncology Unit

Athens, Greece

3

Air Forces Military Hospital, Dep of Medical Oncology

Athens, Greece

4

IASO General Hospital of Athens, 1st Department of Medical Oncology

Athens, Greece